🇺🇸 FDA
Patent

US 11970523

Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof

granted A61KA61K38/00A61K47/542

Quick answer

US patent 11970523 (Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CHINA PHARMACEUTICAL UNIVERSITY
Grant date
Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K47/542, A61P, A61P1/16